ABBV has been in the news 409% more than usual
Jan 12, 2026, 1:31 PM
1.14%
What does ABBV do
AbbVie is a North Chicago-based biopharmaceutical company that develops and sells medicines across various therapeutic areas, employing 50,000 staff since its IPO in January 2013. Key products include Humira, Botox, and NX-13 for ulcerative colitis.
ABBV has been in the news recently: AbbVie will acquire a manufacturing facility from West Pharmaceutical for over $175 million, which will enhance its capabilities and support a significant $10 billion investment in the U.S. by mid-2026. Additionally, AbbVie has partnered with RemeGen on the bispecific antibody RC148, providing RemeGen with $650 million upfront and the potential for up to $4.95 billion in future payments.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.